Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Santiago Palacios, Gabriela Ayala, Gemarilis González, Can L. Badilla-Apuy, Jeannette Marchena, Katia Martínez, Desireé Mostajo, María S. Vernaza, Alejandro Paradas, Luis Hernández, David Vásquez-Awad, Cuauhtémoc Celis-González & Nilson Roberto de Melo. (2023) Combined oral contraceptives: update recommendations of the Latin American contraceptive association. Gynecological Endocrinology 39:1.
Read now
Read now
Andrea R. Genazzani, Tiziana Fidecicchi, Domenico Arduini, Andrea Giannini & Tommaso Simoncini. (2023) Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice. Gynecological Endocrinology 39:1.
Read now
Read now
Suzanne Reed, Carol Koro, Julia DiBello, Kerstin Becker, Anja Bauerfeind, Christian Franke & Klaas Heinemann. (2021) Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism. The European Journal of Contraception & Reproductive Health Care 26:6, pages 439-446.
Read now
Read now
Franca Fruzzetti, Anna Maria Paoletti, Tiziana Fidecicchi, Giulia Posar, Riccardo Giannini & Marco Gambacciani. (2019) Contraception with estradiol valerate and dienogest: adherence to the method. Open Access Journal of Contraception 10, pages 1-6.
Read now
Read now
Angelo Cagnacci, Carlo Bastianelli, Manuela Neri, Antonio Cianci, Chiara Benedetto, Luana Calanni, Michele Vignali, Vincenzo De Leo, Ettore Cicinelli, Giuseppe Borrelli & Annibale Volpe. (2018) Treatment continuation and satisfaction in women using combined oral contraception with nomegestrol acetate and oestradiol: a multicentre, prospective cohort study (BOLERO). The European Journal of Contraception & Reproductive Health Care 23:6, pages 393-399.
Read now
Read now
Ingrid Duijkers, Christine Klipping, Doris Heger-Mahn, Ghassan N. Fayad, Tara L. Frenkl, Sandra M. Cruz & Tjeerd Korver. (2018) Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing. The European Journal of Contraception & Reproductive Health Care 23:4, pages 245-254.
Read now
Read now
Manuela Neri, Maria Elena Malune, Valentina Corda, Bruno Piras, Pierina Zedda, Monica Pilloni, Maria Paola Orani, Valerio Vallerino, Gian Benedetto Melis & Anna Maria Paoletti. (2017) Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC). Gynecological Endocrinology 33:12, pages 958-962.
Read now
Read now
Christian Fiala, Nathalie Chabbert-Buffet, Günther Häusler, Christian Jamin, Iñaki Lete, Paloma Lobo, Rossella E. Nappi & Axelle Pintiaux. (2017) Women’s preferences for menstrual bleeding frequency in 12 European countries: the Inconvenience Due to Women’s Monthly Bleeding (ISY) survey. The European Journal of Contraception & Reproductive Health Care 22:4, pages 268-273.
Read now
Read now
Iñaki Lete, Esther de la Viuda, Ezequiel Pérez-Campos, María Ángeles Gómez Martínez, Rainel Sanchez-de la Rosa, Jesús Novalbos & Rafael Sánchez-Borrego. (2016) Effect on quality of life of switching to combined oral contraception based on natural estrogen: an observational, multicentre, prospective phase IV study (ZOCAL Study). The European Journal of Contraception & Reproductive Health Care 21:4, pages 276-284.
Read now
Read now
Giovanni Grandi, Antonella Napolitano & Angelo Cagnacci. (2016) Metabolic impact of combined hormonal contraceptives containing estradiol. Expert Opinion on Drug Metabolism & Toxicology 12:7, pages 779-787.
Read now
Read now
Rossella E. Nappi, Andrew M. Kaunitz & Johannes Bitzer. (2016) Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians. The European Journal of Contraception & Reproductive Health Care 21:2, pages 106-115.
Read now
Read now
Hannat Akintomide & Sabeena Panicker. (2015) Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability. Open Access Journal of Contraception 6, pages 77-86.
Read now
Read now
Anita L Nelson. (2015) An update on new orally administered contraceptives for women. Expert Opinion on Pharmacotherapy 16:18, pages 2759-2772.
Read now
Read now
Han Witjes, Mitchell D. Creinin, Inger Sundström-Poromaa, Allison Martin Nguyen & Tjeerd Korver. (2015) Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea. The European Journal of Contraception & Reproductive Health Care 20:4, pages 296-307.
Read now
Read now
Luis Bahamondes & M Valeria Bahamondes. (2014) New and emerging contraceptives: a state-of-the-art review. International Journal of Women's Health 6, pages 221-234.
Read now
Read now
Anne Burke. (2013) Nomegestrol acetate-17b-estradiol for oral contraception. Patient Preference and Adherence 7, pages 607-619.
Read now
Read now
Jeffrey T Jensen, Johannes Bitzer & Marco Serrani. (2013) Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol. Open Access Journal of Contraception 4, pages 39-50.
Read now
Read now
Nathalie Chabbert-Buffet, Jan Gerris, Christian Jamin, Stefano Lello, Inaki Lete, Paloma Lobo, Rossella E. Nappi & Axelle Pintiaux. (2013) Toward a new concept of “natural balance” in oral estroprogestin contraception. Gynecological Endocrinology 29:10, pages 891-896.
Read now
Read now
Anita Nelson, Susanne Parke, Dagmar Makalova, Marco Serrani, Santiago Palacios & Uwe Mellinger. (2013) Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: A pooled analysis of three studies conducted in North America and Europe. The European Journal of Contraception & Reproductive Health Care 18:4, pages 264-273.
Read now
Read now
Anita L Nelson. (2012) New developments in oral contraception: clinical utility of estradiol valerate/dienogest (Natazia®) for contraception and for treatment of heavy menstrual bleeding: patient considerations. Open Access Journal of Contraception 3, pages 49-63.
Read now
Read now
Articles from other publishers (59)
Elizabeth Hampson. (2023) Oral contraceptives in the central nervous system: Basic pharmacology, methodological considerations, and current state of the field. Frontiers in Neuroendocrinology 68, pages 101040.
Crossref
Crossref
David F. Archer, Diana Mansour & Jean-Michel Foidart. (2022) Bleeding Patterns of Oral Contraceptives with a Cyclic Dosing Regimen: An Overview. Journal of Clinical Medicine 11:15, pages 4634.
Crossref
Crossref
Emily N. Hilz. (2022) Methods and considerations for the use of hormonal contraceptives in rat models of neurobehavior. Frontiers in Neuroendocrinology 66, pages 101011.
Crossref
Crossref
Moaz A. Al-Gham, Othman A. Baothma, Muhammad Afzal, Sami I. Alzarea, Firoz Anwar, Muhammad Shahid Nad & Imran Kazmi. (2022) Levonorgestrel and Desogestrel Modulate Gut Microbiota and Blood Biochemistry of Female Wistar Rats. International Journal of Pharmacology 18:4, pages 826-841.
Crossref
Crossref
Larisa I. Maltseva & Julia V. Garifullova. (2022) Predictable benefits of folate-containing combined oral contraceptives after abortion in women: review. Gynecology 24:2, pages 72-79.
Crossref
Crossref
Amy J. Voedisch & Wing Kay Fok. (2021) Oestrogen component of COCs: have we finally found a replacement for ethinyl estradiol?. Current Opinion in Obstetrics & Gynecology 33:6, pages 433-439.
Crossref
Crossref
Costantino DI CARLO, Massimo ABBONDANZA, Antonella AGNELLO, Giovanni CAVALLI, Lorenza DRIUL, Massimo PETRIGLIA, Andrea TINELLI, Alessandra TIRELLI, Anna TUSEI & Giovanni GRANDI. (2021) Current and future hormonal contraception in Italy: results from an Italian consensus expert meeting. Minerva Obstetrics and Gynecology 73:5.
Crossref
Crossref
Emily Robertson, Caroline Thew, Natalie Thomas, Leila Karimi & Jayashri Kulkarni. (2021) Pilot Data on the Feasibility And Clinical Outcomes of a Nomegestrol Acetate Oral Contraceptive Pill in Women With Premenstrual Dysphoric Disorder. Frontiers in Endocrinology 12.
Crossref
Crossref
Wan-Lin Zhang, Zhe Dong, Jun-Yan Zhang, Min-Zhi Lyu, Wei Zhang, Jian-Lei Huang & Xin Yang. (2021) Comparison of Risks of Thromboembolism of Drospirenone-Containing and Nondrospirenone -Containing Combined Oral Contraceptive Use: A Meta-Analysis. Reproductive and Developmental Medicine 5:3, pages 154-160.
Crossref
Crossref
Yuliya E. Dobrokhotova, Metanat R. Narimanova, Svetlana A. Khlynova, Liudmila V. Saprykina & Irina Iu. Il’ina. (2021) Post-abortion contraception: how to make the right choice?. Gynecology 23:2, pages 205-209.
Crossref
Crossref
Martin Birkhaeuser. 2021. Female and Male Contraception. Female and Male Contraception
361
397
.
Sarah Cipriani, Tommaso Todisco, Irene Scavello, Vincenza Di Stasi, Elisa Maseroli & Linda Vignozzi. (2019) Obesity and hormonal contraception: an overview and a clinician’s practical guide. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 25:5, pages 1129-1140.
Crossref
Crossref
John S. Barbieri, Nandita Mitra, David J. Margolis, Cynthia C. Harper, Arash Mostaghimi & Katrina Abuabara. (2020) Influence of Contraception Class on Incidence and Severity of Acne Vulgaris. Obstetrics & Gynecology 135:6, pages 1306-1312.
Crossref
Crossref
Bao-Cheng Xie, Shu-Yong Song, Xiao-Yang Xie, Yu-Tong Sun, Xiao-Yuan Zhang, Dao-Hua Xu & Yun-Sheng Huang. (2019) Isolation, synthesis, and cytotoxicity evaluation of two impurities in nomegestrol acetate. Archiv der Pharmazie 352:3, pages 1800295.
Crossref
Crossref
John S. Barbieri, Natalie Spaccarelli, David J. Margolis & William D. James. (2019) Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments. Journal of the American Academy of Dermatology 80:2, pages 538-549.
Crossref
Crossref
. (2019) FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception. BMJ Sexual & Reproductive Health 45:Suppl 1, pages 1-93.
Crossref
Crossref
G. B. Dikke. (2018) Therapeutic tactics with violations of the menstrual cycle caused by ovulative dysfunction. Medical Council:13, pages 40-44.
Crossref
Crossref
Herjan J T Coelingh Bennink, Yvette Zimmerman, Carole Verhoeven, Alice E Dutman, Tjeert Mensinga, Cornelis Kluft, Yacov Reisman & Frans M J Debruyne. (2018) A Dose-Escalating Study With the Fetal Estrogen Estetrol in Healthy Men. The Journal of Clinical Endocrinology & Metabolism 103:9, pages 3239-3249.
Crossref
Crossref
Carina Oedingen, Stefan Scholz & Oliver Razum. (2018) Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose. Thrombosis Research 165, pages 68-78.
Crossref
Crossref
Panagiotis Tsikouras, Dorelia Deuteraiou, Anastasia Bothou, Xanthi Anthoulaki, Anna Chalkidou, Eleftherios Chatzimichael, Fotini Gaitatzi, Bachar Manav, Zacharoula Koukouli, Stefanos Zervoudis, Grigorios Trypsianis & George Galazios. (2018) Ten Years of Experience in Contraception Options for Teenagers in a Family Planning Center in Thrace and Review of the Literature. International Journal of Environmental Research and Public Health 15:2, pages 348.
Crossref
Crossref
Helena Kopp Kallner. (2018) Benefits of reversible contraception. F1000Research 7, pages 973.
Crossref
Crossref
Salvatore CarusoStefano CianciMaria CariolaValentina FavaSalvatore Di PasquaAntonio Cianci. (2017)
Improvement of Low Sexual Desire Due to Antiandrogenic Combined Oral Contraceptives After Switching to an Oral Contraceptive Containing 17
β
-Estradiol
. Journal of Women's Health 26:7, pages 728-734.
Crossref
Crossref
Diana Mansour. (2017) Postponing menstruation: choices and concerns. Journal of Family Planning and Reproductive Health Care 43:2, pages 160-161.
Crossref
Crossref
Diana Mansour, Carolyn Westhoff, Uma Kher & Tjeerd Korver. (2017) Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17?-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women. Contraception 95:4, pages 390-397.
Crossref
Crossref
Cecilia Lundin, Kristina Gemzell Danielsson, Marie Bixo, Lena Moby, Hanna Bengtsdotter, Izabella Jawad, Lena Marions, Jan Brynhildsen, Agota Malmborg, Ingela Lindh & Inger Sundström Poromaa. (2017) Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle—A double-blind, placebo-controlled randomized trial. Psychoneuroendocrinology 76, pages 135-143.
Crossref
Crossref
G. B. Dikke. (2016) How to reduce the number of side effects produced by COCs and improve adherence: simple tips for practitioners. Medical Council:2, pages 10-13.
Crossref
Crossref
Dan Apter, Yvette Zimmerman, Louise Beekman, Marie Mawet, Catherine Maillard, Jean-Michel Foidart & Herjan J.T. Coelingh Bennink. (2016) Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA). Contraception 94:4, pages 366-373.
Crossref
Crossref
Laureen M Lopez, Alissa Bernholc, Mario Chen, Thomas W Grey, Conrad Otterness, Carolyn Westhoff, Alison Edelman & Frans M Helmerhorst. (2016) Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database of Systematic Reviews 2016:8.
Crossref
Crossref
Nicolás Mendoza, Esperanza Soto & Rafael Sánchez-Borrego. (2016) Do women aged over 40 need different counseling on combined hormonal contraception?. Maturitas 87, pages 79-83.
Crossref
Crossref
Teun M. Post, Mireille Gerrits, Thomas Kerbusch & Rik de Greef. (2016) Prediction of nomegestrol acetate pharmacokinetics in healthy female adolescents and adults by whole-body physiology-based pharmacokinetic modelling and clinical validation. Contraception 93:2, pages 133-138.
Crossref
Crossref
Jamie Krashin, Jennifer H Tang, Sheila Mody & Laureen M Lopez. (2015) Hormonal and intrauterine methods for contraception for women aged 25 years and younger. Cochrane Database of Systematic Reviews 2015:8.
Crossref
Crossref
V. Bettoli, S. Zauli & A. Virgili. (2015) Is hormonal treatment still an option in acne today?. British Journal of Dermatology 172, pages 37-46.
Crossref
Crossref
Ginger Evans & Eliza L. Sutton. (2015) Oral Contraception. Medical Clinics of North America 99:3, pages 479-503.
Crossref
Crossref
George K. Creatsas. 2015. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology
41
45
.
PAMELA A. ROYER & KIRTLY P. JONES. (2014) Progestins for Contraception. Clinical Obstetrics & Gynecology 57:4, pages 644-658.
Crossref
Crossref
Jan Brynhildsen. (2014)
Combined hormonal contraceptives: prescribing patterns, compliance, and benefits
versus
risks
. Therapeutic Advances in Drug Safety 5:5, pages 201-213.
Crossref
Crossref
. (2014) ?Zoely: a new combined oral contraceptive. Drug and Therapeutics Bulletin 52:8, pages 90-93.
Crossref
Crossref
Monica V. Dragoman. (2014) The combined oral contraceptive pill- recent developments, risks and benefits. Best Practice & Research Clinical Obstetrics & Gynaecology 28:6, pages 825-834.
Crossref
Crossref
Nicolas Mendoza & Rafael Sanchez-Borrego. (2014) Classical and newly recognised non-contraceptive benefits of combined hormonal contraceptive use in women over 40. Maturitas 78:1, pages 45-50.
Crossref
Crossref
He-Lin Lu, Zong-Wen Wu, Shu-Yong Song, Xiao-Dan Liao, Yan Zhu & Yun-Sheng Huang. (2014) An Improved Synthesis of Nomegestrol Acetate. Organic Process Research & Development 18:3, pages 431-436.
Crossref
Crossref
Anita NelsonSusanne ParkeUwe MellingerEdio ZampaglioneAnja Schmidt. (2014) Efficacy and Safety of a Combined Oral Contraceptive Containing Estradiol Valerate/Dienogest: Results from a Clinical Study Conducted in North America. Journal of Women's Health 23:3, pages 204-210.
Crossref
Crossref
Marta M. Millán & Santos Castañeda. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions
731
745
.
George K. Creatsas & Maria Creatsas. 2014. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology
25
27
.
Laura Percy & Diana Mansour. (2013) Tailoring oral contraceptive pills to meet the needs of women. Journal of Family Planning and Reproductive Health Care 39:4, pages 237-240.
Crossref
Crossref
D. Foth, T. Römer & H.-J. Ahrendt. (2013) Hormonelle Kontrazeption mit östradiolhaltigen KombinationspräparatenHormonal contraception with estradiol-containing combined preparations. Gynäkologische Endokrinologie 11:3, pages 162-167.
Crossref
Crossref
David Crook. 2013. Contraception. Contraception
35
41
.
Lee P Shulman. (2013) Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24/4 regimen. Journal of Family Planning and Reproductive Health Care 39:3, pages 211-216.
Crossref
Crossref
Frank Z. Stanczyk, David F. Archer & Bhagu R. Bhavnani. (2013) Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception 87:6, pages 706-727.
Crossref
Crossref
Mireille G.F. Gerrits, Peter G. Schnabel, Teun M. Post & Pierre A.M. Peeters. (2013) Pharmacokinetic profile of nomegestrol acetate and 17?-estradiol after multiple and single dosing in healthy women. Contraception 87:2, pages 193-200.
Crossref
Crossref
Sophie Christin-Maitre. (2013) History of oral contraceptive drugs and their use worldwide. Best Practice & Research Clinical Endocrinology & Metabolism 27:1, pages 3-12.
Crossref
Crossref
Sophie Christin-Maitre, Emmanuelle Laroche & Léopoldine Bricaire. (2013) A New Contraceptive Pill Containing 17β-Estradiol and Nomegestrol Acetate. Women's Health 9:1, pages 13-23.
Crossref
Crossref
Katherine A. Lyseng-Williamson, Lily P. H. Yang & Greg L. Plosker. (2012) Nomegestrol acetate/estradiol: a guide to its use in oral contraception. Drugs & Therapy Perspectives 29:1, pages 1-6.
Crossref
Crossref
Uwe Fricke & Ulrich Schwabe. 2013. Arzneiverordnungs-Report 2013. Arzneiverordnungs-Report 2013
47
120
.
TERJE SØRDAL, PAUL GROB & CAROLE VERHOEVEN. (2012) Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β‐estradiol in comparison to levonorgestrel/ethinylestradiol. Acta Obstetricia et Gynecologica Scandinavica 91:11, pages 1279-1285.
Crossref
Crossref
Lily P.H. Yang & Greg L. Plosker. (2012) Nomegestrol Acetate/Estradiol. Drugs 72:14, pages 1917-1928.
Crossref
Crossref
Ayodele O Arowojolu, Maria F Gallo, Laureen M Lopez & David A Grimes. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Carolyn Westhoff, Andrew M. Kaunitz, Tjeerd Korver, Werner Sommer, Luis Bahamondes, Philip Darney & Carole Verhoeven. (2012) Efficacy, Safety, and Tolerability of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate and 17β-Estradiol. Obstetrics & Gynecology 119:5, pages 989-999.
Crossref
Crossref
Xiangyan Ruan, Harald Seeger & Alfred O. Mueck. (2012) The pharmacology of nomegestrol acetate. Maturitas 71:4, pages 345-353.
Crossref
Crossref
Harry A van Diepen. (2012) Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative. Reproductive Biology and Endocrinology 10:1, pages 85.
Crossref
Crossref